Biohm Technologies

Biohm Technologies is a company dedicated to developing microbiome-based health solutions, focusing on gut health by analyzing both bacterial and fungal populations to enhance individual well-being. Biohm Technologies creates innovative microbiome assessment tools that provide health insights. The firm was founded in 2016 in Cleveland, US, and has undergone strategic pivots to refine its product offerings. The founder, Dr.

Mahmoud Ghannoum, is a recognized leader in microbiome research. The company has completed a total of 2 deals, with the most recent funding round taking place on April 2, 2025, raising USD 7. 50 mn led by VTC Ventures and supported by investors including Aztec Capital Management and Cleveland Life Science Advisors. Biohm Technologies specializes in microbiome-based health solutions, focusing on both bacterial and fungal populations in the gut.

Their flagship product, the Gut Health Test Kit, allows consumers to assess their gut health through comprehensive analysis of fungal and bacterial species, providing personalized nutrition, lifestyle, and supplementation recommendations. This innovative testing solution is designed for health-conscious individuals looking to enhance their digestive and immune health. Biohm's products are informed by over 40 years of research conducted by Dr. Mahmoud Ghannoum, a pioneer in microbiome studies.

The company's offerings are primarily targeted at the North American and European markets, appealing to consumers interested in advanced gut health solutions and personalized approaches to dietary supplementation. Biohm Technologies generates revenue through direct-to-consumer sales of their microbiome assessment products and personalized health solutions. The company employs a transactional structure that includes individual purchases of the Gut Health Test Kit and potential partnerships with retailers in the health and wellness sector. These partnerships facilitate broader distribution and accessibility of Biohm's products to a wider audience.

Pricing plans for the company's flagship offerings are structured to reflect the advanced scientific research and technology underpinning their development. By leveraging both B2B and direct-to-consumer channels, Biohm positions itself to effectively meet the growing demand for microbiome-based health products. In April 2025, Biohm Technologies raised USD 7. 50 mn in venture funding from new investors Praesidium and Sparkfood.

The company plans to utilize this funding for product advancement, which includes upcoming releases of new microbiome assessment tools. Additionally, Biohm Technologies aims to expand its market presence into new geographic regions beyond North America and Europe, with specific timelines for these expansions currently under development.